RCERECCE PHARMACEUTICALS LTD
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 19 Aug 2026, 21:02 | HREC Approves Comparator Study for Pivotal Phase 3 DFI | Company Update | MS | 11001 | |
| 7 Aug 2026, 02:55 | Change of Director's Interest Notices (x4) | Director Interests | — | 02009 | |
| 5 Aug 2026, 02:12 | Cleansing Notice | Securities Administration | — | 06018 | |
| 3 Aug 2026, 18:23 | Application for quotation of securities - RCE | Other | — | 06020 | |
| 31 July 2026, 21:32 | Completion of Share Purchase Plan and Shortfall Notice | Capital Raising | — | 06017 | |
| 31 July 2026, 21:30 | Application for quotation of securities - RCE | Other | — | 06020 | |
| 31 July 2026, 19:04 | Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007 | |
| 30 July 2026, 20:38 | U.S. Government Releases US$66.9B AMR Biodefense Strategy | Company Update | — | 11001 | |
| 21 July 2026, 22:50 | Investor Webinar - Q4 FY26 Investor Presentation Deck | Presentations | — | 03026, 19009 | |
| 21 July 2026, 22:27 | Investor Webinar - 2.30PM (AEST) 21 July 2026 | Presentations | — | 14014 | |
| 21 July 2026, 22:20 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 20 July 2026, 19:33 | Update - Proposed issue of securities - RCE | Securities Administration | — | 06013 | |
| 20 July 2026, 19:29 | Extension to Share Purchase Plan Closing Date | Capital Raising | — | 06017 | |
| 14 July 2026, 18:56 | Vietnamese Patent Granted for RECCE Anti-Infectives | Company Update | MS | 11001 | |
| 6 July 2026, 19:06 | Share Purchase Plan - Letter and Offer Booklet | Capital Raising | — | 06017, 16002 | |
| 4 July 2026, 00:31 | Cleansing Notice | Securities Administration | — | 06018 | |
| 4 July 2026, 00:25 | Application for quotation of securities - RCE | Other | — | 06020 | |
| 3 July 2026, 02:26 | Notification of cessation of securities - RCE | Other | — | 06027 | |
| 1 July 2026, 21:30 | Cleansing Notice | Securities Administration | — | 06018 | |
| 1 July 2026, 21:24 | Application for quotation of securities - RCE | Other | — | 06020 | |
| 1 July 2026, 21:10 | Application for quotation of securities - RCE | Other | — | 06020 | |
| 1 July 2026, 21:04 | Application for quotation of securities - RCE | Other | — | 06020 | |
| 1 July 2026, 19:07 | AUD $3.7M Income Tax Refund Received | Company Update | MS | 11001, 12008 | |
| 27 June 2026, 04:00 | Proposed issue of securities - RCE | Securities Administration | — | 06013 | |
| 26 June 2026, 20:35 | RCE Investor Presentation | Presentations | — | 03026 | |
| 26 June 2026, 20:19 | Proposed issue of securities - RCE | Securities Administration | — | 06013 | |
| 26 June 2026, 20:03 | Placement & SPP to raise $8 million | Capital Raising | MS | 06003, 06017, 09014 | |
| 24 June 2026, 20:08 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 24 June 2026, 19:54 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 22 June 2026, 20:03 | HREC Approval Accelerates Global Phase 3 DFI Strategy | Company Update | MS | 11001 | |
| 27 May 2026, 23:49 | Addendum to Recce Signs Middle East Licensing Term Sheet | Company Update | MS | 11001 | |
| 27 May 2026, 19:48 | Recce Signs Middle East Licensing Term Sheet | Company Update | MS | 11001 | |
| 1 May 2026, 03:03 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 21 Apr 2026, 20:52 | Positive Regulatory Inspection Outcome for Phase 3 Trial | Company Update | — | 11001 | |
| 16 Apr 2026, 03:28 | Notification of cessation of securities - RCE | Other | — | 06027 | |
| 24 Mar 2026, 22:52 | Brazil Patent Granted for RECCE Anti-Infectives | Company Update | MS | 11001 | |
| 19 Mar 2026, 21:43 | RCE Investor Webinar Presentation Deck | Presentations | MS | 03026 | |
| 18 Mar 2026, 02:00 | RCE Investor Webinar Presentation | Presentations | — | 14014 | |
| 28 Feb 2026, 05:02 | Appendix 4D and Interim Financial Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 25 Feb 2026, 04:51 | Change of Director's Interest Notices (x5) | Director Interests | — | 02009 | |
| 25 Feb 2026, 04:17 | Notification of cessation of securities - RCE | Other | — | 06027 | |
| 2 Feb 2026, 19:58 | Recce Enters Second U.S. Department of Defense R&D Agreement | Company Update | MS | 11001 | |
| 31 Jan 2026, 00:01 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 14 Jan 2026, 21:37 | AUD $5.3m R&D Rebate Received | Periodic Reports | MS | 03014, 12008 | |
| 16 Dec 2025, 20:48 | RCE Awarded Advanced Overseas Finding up to A$85m | Periodic Reports | MS | 03014 | |
| 27 Nov 2025, 21:05 | Hong Kong Patent Granted for RECCE Anti-Infectives | Company Update | MS | 11001 | |
| 26 Nov 2025, 20:50 | Positive Efficacy Data for Inhaled R327 in HAP/VAP Model | Company Update | MS | 11001 | |
| 15 Nov 2025, 03:08 | Passing of Dr Graham Melrose - Recce founder and inventor | Company Administration | — | 12008 | |
| 6 Nov 2025, 01:09 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 5 Nov 2025, 19:58 | AGM Presentation | Presentations | — | 03026, 15002 |
1–50 of 63
1 / 2